Is there an indirect way to invest in Impact Therap-b?

Direct listed exposure is available, so an indirect proxy is usually unnecessary.

Does Impact Therap-b have a stock symbol?

The stock symbol is 7630.HK on HKSE.

Impact Therap-b

Status: Publicly traded

Direct answer

Impact Therap-b is publicly traded on HKSE under the ticker 7630.HK.

IMPACT Therapeutics, a biotechnology firm, specializes in the discovery and advancement of precision anti-cancer treatments rooted in synthetic lethality, operating across China and international markets. The company's primary offering, Senaparib (IMP4297), is a PARP1/2 inhibitor currently deployed as a first-line maintenance therapy for ovarian cancer. Beyond this, Impact Therapeutics maintains a robust pipeline of...

Can you invest in Impact Therap-b?

Yes. Impact Therap-b is publicly traded on HKSE under the ticker 7630.HK.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Impact Therap-b

Detailed equity research is provided by MarketSnap.